| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alamar Biosciences, Inc. (ALMR) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. ALMR is classified in the Medical Devices industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.59M | $106.59M | +235.3K | |
| CEO | 1.86M | $43.30M | - | |
| COO | 650.0K | $15.10M | - | |
| CFO | 37.2K | $864.6K | - | |
| Dir | 0 | - | +235.3K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Illumina Innovation Fund II Gp, L.l.c. | 10% Owner | Buy | 235,294 | $17.00 | $3,999,998.00 | +86.6% | |
| Apr 20, 2026 | Naclerio Nicholas | Director | Buy | 235,294 | $17.00 | $3,999,998.00 | +86.6% |